ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 7c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance
• MDxHealth SA (MDXH) Misses Q2 EPS by 1c ; Offers Guidance
• Audioeye, Inc. (AEYE) Misses Q2 EPS by 28c; Offer Guidance